Login / Signup

Adherence to oral therapies among patients with renal cell carcinoma: Post hoc analysis of the ECOG-ACRIN E2805 trial.

Caitlin C MurphyHannah M FullingtonDavid E GerberIsaac Alex BowmanManeka PuligandlaJanice P DutcherRobert S DiPaolaNaomi B Haas
Published in: Cancer medicine (2021)
This trial is registered with ClinicalTrials.gov, number NCT00326898.
Keyphrases
  • renal cell carcinoma
  • phase iii
  • study protocol
  • phase ii
  • clinical trial
  • open label
  • type diabetes
  • skeletal muscle
  • weight loss